A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 10, 1998, Pages 3487-3492

  Kalmijn, S ^a,d   Launer, L J ^a,b   Stolk, R P ^c   De Jong, F H ^a   Pols, H A P ^a   Hofman, A ^a   Breteler, M M B ^a   Lamberts, S W J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; PRASTERONE SULFATE;

ADULT; AGED; AGING; ANDROGEN BLOOD LEVEL; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; NETHERLANDS; PRIORITY JOURNAL;

EID: 0031796078     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.10.5164     Document Type: Article

References (51)

1. McEwen BS, Cameron H, Chao HM, et al. 1994 Resolving a mystery: progress in understanding the function of adrenal steroid receptors in hippocampus. Prog Brain Res. 100:149-155.
2. Diamond DM, Branch BJ, Fleshner M. 1996 The neurosteroid dehydroepiandrosterone sulfate (DHEAS) enhances hippocampal primed burst, but not long-term, potentiation. Neurosci Lett. 202:204-208.
3. O'Brien JT, Schweitzer I, Ames D, Tuckwell V, Mastwyk M. 1994 Cortisol suppression by dexamethasone in the healthy elderly: effects of age, dexamethasone levels, and cognitive function. Biol Psychiatry. 36:389-394.
4. Sapolsky RM, Uno H, Rebert CS, Finch CE. 1990 Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci. 10:2897-2902.
5. Lupien SJ, Gaudreau S, Tchiteya BM, et al. 1997 Stress-induced declarative memory impairment in healthy elderly subjects: relationship to cortisol reactivity. J Clin Endocrinol Metab. 82:2070-2075.
6. Seeman TE, McEwen BS, Singer BH, Albert MS, Rowe JW. 1997 Increase in urinary cortisol excretion and memory declines: MacArthur studies on successful aging. J Clin Endocrinol Metab. 82:2458-2465.
7. Lupien S, Lecours AR, Lussier I, Schwartz G, Nair NPV, Meaney MJ. 1994 Basal cortisol levels and cognitive deficits in human aging. J Neurosci 14:2893-2903.
8. Gottfries CG, Balldin J, Blennow K, et al. 1994 Regulation of the hypothalamic-pituitary- adrenal axis in dementia disorders. Ann NY Acad Sci 746:336-343.
9. Weiner MF, Vobach S, Svetlik D, Risser RC. 1993 Cortisol secretion and Alzheimer's disease progression: a preliminary report. Biol Psychiatry 34:158-161.
10. Hatzinger M, Z'Brun A, Hemmeter U, et al. 1995 Hypothalamic-pituitary-adrenal system function in patients with Alzheimer's disease. Neurobiol Aging. 16:205-209.
11. Nãsman B, Olsson T, Viitanen M, Carlström K. 1995 A subtle disturbance in the feedback regulation of the hypothalamic-pituitary-adrenal axis in the early phase of Alzheimer's disease. Psychoneuroendocrinology. 20:211-220.
12. Vermeulen A. 1995 Dehydroepiandrosterone sulfate, and aging. Ann NY Acad Sci. 774:121-125.
13. Roberts E, Bologa L, Flood JF, Smith GE. 1987 Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice. Brain Res. 406:357-362.
14. Bologa L, Sharma J, Roberts E. 1987 Dehydroepiandrosterone, and its sulfated derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures. J Neurosci Res. 17:225-234.
15. Yoo A, Harris J, Dubrovsky B. 1996 Dose-response study of dehydroepiandrosterone sulfate on dentate gyrus long-term potentiation. Exp Neurol. 137:151-156.
16. Näsman B, Olsson T, Bäckström T, et al. 1991 Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia. Biol Psychiatry. 30:684-690.
17. Schneider LS, Hinsey M, Lyness S. 1992 Plasma dehydroepiandrosterone sulfate in Alzheimer's disease. Biol Psychiatry. 31:205-208.
18. Legrain S, Berr C, Frenoy N, Gourlet V, Debuire B, Baulieu E-E. 1995 Dehydroepiandrosterone sulfate in a long-term care aged population. Gerontology. 41:343-351.
19. Barrett-Connor E, Edelstein S. 1994 A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: the Rancho Bemardo Study. J Am Geriatr Soc. 42:420-423.
20. Hofman A, Grobbee DE, de Jong PTVM, van den Ouweland FA. 1991 Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 7:403-422.
21. Nugent CA, Nichols T, Tyler FH. 1965 Diagnosis of Cushing's syndrome. Arch Intern Med. 166:172-176.
22. Södergard R, Bäckström T, Shanbhag V, Carstensen H. 1982 Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. J Steroid Biochem. 16:801-810.
23. Blauer KL, Poth M, Rogers WM, Bernton EW. 1991 Dehydroepiandrosterone antagonises the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology. 129:3174-3179.
24. May M, Holmes E, Rogers W, Poth M. 1991 Protection from glucocorticoid induced thymic involution by dehydroepiandrosterone. Life Sci. 46:1627-1631.
25. Shafagoj Y, Opuku J, Quereshi D, Regelson W, Kalimi M. 1992 Dehydroepiandrosterone prevents dexamethasone-induced hypertension in rats. Am J Physiol. 263:E210-E213.
26. Folstein MF, Folstein SE, McHugh PR. 1975 'Mini-Mental State.' A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12:189-198.
27. Launer LJ. 1992 Overview of incidence studies of dementia conducted in Europe. Neuroepidemiology. 11(Suppl 1):2-13.
28. Fillenbaum GG, George LK, Blazer DG. 1988 Scoring nonresponse on the Mini-Mental State Examination. Psychol Med. 18:1021-1025.
29. Siu AL. 1991 Screening for dementia and investigating its causes. Ann Intern Med. 115:122-132.
30. Radloff LS. 1977 The CES-D scale: a self-report depression scale for research in the general population. Appl Psychological Measurement. 1:385-401.
31. Zigmond AS, Snaith RP. 1983 The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 67:361-370.
32. Berlinger WG, Potter JF. 1991 Low body mass index in demented outpatients. J Am Geratr Soc. 39:973-978.
33. Stolk RP, Lamberts SWJ, de Jong FH, Pols HAP, Grobbee DE. 1996 Gender differences in the association between cortisol and insulin in healthy subjects. J Endocrinol. 149:313-318.
34. Feher EP, Mahurin RK, Doody RS, Cooke N, Sims J, Pirozzolo FJ. 1942 Establishing the limits of the Mini-Mental State. Examination of 'subtests.' Arch Neurol. 49:87-92.
35. Tombaugh TN, McIntyre NJ. 1992 The Mini-Mental state examination: a comprehensive review. J Am Geriatr Soc. 40:922-935.
36. Belle G van, Uhlmann RF, Hughes JP, Larson EB. 1990 Reliability of estimates of change in mental status test performance in senile dementia of the Alzheimer type. J Clin Epidemiol. 43:589-595.
37. Lichtenberg PA, Ross T, Millis SR, Manning CA. 1995 The relationship between depression and cognition in older adults: a cross-validation study. J Gerontol Psychol Sci. 50B:P25-P32.
38. Osran H, Reist C, Chen C-C, Lifrak ET, Chicz-DeMet A, Parker LN. 1993 Adrenal androgens and cortisol in major depression. Am J Psychiatry. 150:806-809.
39. Mauri M, Sinforiani E, Bono G, et al. 1993 Memory impairment in Cushing's disease. Acta Neurol Scand. 87:52-55.
40. Wolkowitz OM. 1994 Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology. 19:233-255.
41. Woolley CS, Gould E, McEwen BS. 1990 Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 531:225-231.
42. Sapolsky RM, Krey LC, McEwen BS. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci. 1985:1222-1227.
43. DeLeon MJ, McRae T, Tsai JR, et al. 1988 Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy. Lancet. 2:391-392.
44. Starkman MN, Gebarski SS, Berent S, Schteingart DE. 1992 Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry. 32:756-765.
45. Sapolsky RM, Krey LC, McEwen BS. 1986 The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev. 7:284-301.
46. Rudman D, Shetty KR, Mattson DE. 1990 Plasma dehydroepiandrosterone sulfate in nursing home men. J Am Geriatr Soc. 38:421-427.
47. Wolkowitz OM, Reus VI, Roberts E, et al. 1995 Antidepressant and cognition-enhancing effects of DHEA in major depression. Ann NY Acad Sci. 774:337-339.
48. Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J. 1996 Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J Clin Endocrinol Metab. 81:3951-3960.
49. Majewska MD. 1995 Neuronal actions of dehydroepiandrosterone. Possible roles in brain development, aging, memory, and affect. Ann NY Acad Sci. 774:111-120.
50. Vande Wiele RL, MacDonald PC, Gurpide E, Lieberman S. 1963 Studies on the secretion and interconversion of the androgens. Recent Prog Horm Res. 19:275-310.
51. Paganini-Hill A, Henderson VW. 1994 Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol. 140:256-261.